ImmunoBrain Checkpoint Awarded Alzheimer’s Association Grant to Support Phase I Trial Investigating Novel Immunotherapeutic Approach to Treat Alzheimer’s Disease

NEW YORK, Sept. 1, (Korea Bizwire) – ImmunoBrain Checkpoint Inc. (“IBC”) announced today that it has been awarded a $1,000,000 grant from the Alzheimer’s Association under the 2020 Part the Cloud-Bill Gates Partnership Grant Program to support a phase 1 clinical trial to examine safety and activity of its proprietary antibody, IBC-Ab002, targeted to enhance the [...]